betamethasone-17,21-dipropionate has been researched along with ciclopirox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baptista, A; Coelho, H; Furtado, A; Lopes, J; Rocha, N; Sousa, C; Teixeira, D | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
2 other study(ies) available for betamethasone-17,21-dipropionate and ciclopirox
| Article | Year |
|---|---|
Adult vulvar Langerhans cell histiocytosis: a rare presentation.
Topics: Adult; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents; Betamethasone; Ciclopirox; Cladribine; Diabetes Insipidus; Female; Histiocytosis, Langerhans-Cell; Humans; Vulvar Diseases | 2020 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |